Cisplatin treatment had a profound immunological effect by significantly reducing the levels of the primary tumor cytokines B-cell activating factor (BAFF) and interleukin (IL)-1β compared to vehicle treatment (Supplementary Fig. 8a). Here, IL1B is linked to neoplasm.